JPMorgan Chase & Co’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $314K | Sell |
14,409
-1,920
| -12% | -$41.8K | ﹤0.01% | 4260 |
|
|
2025
Q1 | $302K | Buy |
16,329
+644
| +4% | +$11.9K | ﹤0.01% | 4282 |
|
|
2024
Q4 | $418K | Buy |
15,685
+3,240
| +26% | +$86.3K | ﹤0.01% | 4231 |
|
|
2024
Q3 | $292K | Buy |
12,445
+8,050
| +183% | +$189K | ﹤0.01% | 4298 |
|
|
2024
Q2 | $81.5K | Sell |
4,395
-8,161
| -65% | -$151K | ﹤0.01% | 4702 |
|
|
2024
Q1 | $224K | Buy |
+12,556
| New | +$224K | ﹤0.01% | 4398 |
|